Myriad Genetics MYGN Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $126M+24.8% | $151.3M+35.2% | $154.8M+41.0% | $83.7M-17.3% | $101M-4.4% | ||
| $1.6M-82.6% | —— | $9.4M-5.1% | $9.3M+5.7% | $9.2M+5.7% | ||
| $123.8M+2.8% | $115.3M-4.9% | $118M-6.1% | $137M+16.3% | $120.4M+1.9% | ||
| $27.9M-1.4% | $30.6M+11.3% | $31.6M+20.6% | $28.7M+10.0% | $28.3M+15.0% | ||
| $34.7M+7.1% | $25.1M-17.7% | $36M+47.5% | $29.9M+38.4% | $32.4M+30.1% | ||
| $2M-86.0% | $12M-26.8% | $13.8M-18.8% | $14.3M-22.3% | $14.3M-22.3% | ||
| $312.8M+8.9% | $332.6M+11.6% | $344.8M+17.6% | $284.3M-2.5% | $287.2M-1.1% | ||
| $111.5M-2.2% | $114M-2.9% | $111.4M-3.5% | $113M-2.8% | $114M-3.8% | ||
| $90.5M+8.4% | $87.9M-19.8% | $83.3M-29.0% | $79.4M-30.5% | $83.5M-24.6% | ||
| $51M-4.5% | $49.4M-10.2% | $50.6M-11.8% | $51.2M-9.4% | $53.4M-9.3% | ||
| $47.1M-83.5% | $51.6M-82.0% | $51.6M-82.0% | $51.6M-82.0% | $286.3M-0.2% | ||
| $145.7M-43.4% | $153.4M-41.5% | $163.1M-47.8% | $170.1M-46.8% | $257.5M-24.5% | ||
| $5.6M-27.3% | $5.6M-34.1% | $6.6M-60.0% | $7.1M-52.3% | $7.7M-48.3% | ||
| $673.7M-33.0% | $706.6M-31.2% | $728.1M-32.7% | $677.3M-37.6% | $1.01B-9.4% | ||
| $32.6M+16.0% | $30M-7.1% | $31.8M+7.4% | $30.9M-7.2% | $28.1M-15.1% | ||
| $39.8M-7.4% | $51.2M-57.0% | $47.3M-8.0% | $40.5M-10.4% | $43M+13.8% | ||
| $7.1M-34.9% | $6.9M-46.1% | $7.9M-41.5% | $9M-32.3% | $10.9M-21.0% | ||
| $6.6M-26.7% | $5.7M+11.8% | $5.1M+21.4% | $5.1M+10.9% | $9M+47.5% | ||
| $130.2M-13.8% | $133.8M-18.5% | $148M-4.1% | $199.9M+34.3% | $151.1M+3.4% | ||
| $120.3M+103% | $119.9M+203% | $119.5M+206% | $0-100% | $59.3M+53.2% | ||
| $84.1M-3.8% | $83M-5.6% | $84.9M-6.3% | $86.2M-5.5% | $87.4M-7.3% | ||
| —— | $89.9M-10.7% | —— | —— | —— | ||
| $1.7M-15.0% | $1.9M-13.6% | $1.7M-95.0% | $1.9M-94.5% | $2M-95.1% | ||
| $336.3M+11.7% | $338.6M+3.7% | $355.3M+1.6% | $289.2M-16.1% | $301.2M-14.1% | ||
| 150M0.0% | 900K0.0% | 150M0.0% | 150M0.0% | 150M0.0% | ||
| $1.49B+2.1% | $1.49B+2.1% | $1.49B+2.9% | $1.47B+2.7% | $1.46B+3.0% | ||
| -$1.16B-52.8% | -$1.12B-48.3% | -$1.11B-56.1% | -$1.09B-57.1% | -$756.9M-15.5% | ||
| $700K+217% | $800K+200% | -$100K0.0% | -$100K+97.5% | -$600K+85.7% | ||
| $337.4M-52.1% | $368M-47.5% | $372.8M-49.1% | $388.1M-47.6% | $704.9M-7.2% | ||
| $673.7M-33.0% | $706.6M-31.2% | $728.1M-32.7% | $677.3M-37.6% | $1.01B-9.4% | ||
| $5.6M-27.3% | $5.6M-34.1% | $6.6M-60.0% | $7.1M-52.3% | $7.7M-48.3% | ||
| $512M-14.1% | $511.9M-13.4% | $515.9M-18.3% | $517.7M-17.5% | $595.9M-8.0% | ||
| $51M-4.5% | $49.4M-10.2% | $50.6M-11.8% | $51.2M-9.4% | $53.4M-9.3% | ||
| $145.7M-43.4% | $153.4M-41.5% | $163.1M-47.8% | $170.1M-46.8% | $257.5M-24.5% | ||
| $145.7M-43.4% | $153.4M-41.5% | $163.1M-47.8% | $170.1M-46.8% | $257.5M-24.5% | ||
| $51M-4.5% | $49.4M-10.2% | $50.6M-11.8% | $51.2M-9.4% | $53.4M-9.3% | ||
| $5.6M-27.3% | $5.6M-34.1% | $6.6M-60.0% | $7.1M-52.3% | $7.7M-48.3% | ||
| $202M+2.3% | $201.9M-11.1% | $194.7M-16.3% | $192.4M-16.9% | $197.5M-13.9% | ||
| $51M-4.5% | $49.4M-10.2% | $50.6M-11.8% | $51.2M-9.4% | $53.4M-9.3% | ||
| $5.6M-27.3% | $5.6M-34.1% | $6.6M-60.0% | $7.1M-52.3% | $7.7M-48.3% | ||
| $39.8M-7.4% | $51.2M-10.8% | $47.3M-8.0% | $40.5M-10.4% | $43M+13.8% | ||
| $4.7M-21.7% | $4.7M-27.7% | $5.6M-15.2% | $5.7M-10.9% | $6M+5.3% | ||
| $90.5M-19.3% | $96.9M-18.6% | $108.3M-2.6% | $100.6M+2.3% | $112.1M+13.0% | ||
| $90.5M-19.3% | $96.9M-18.6% | $108.3M-2.6% | $100.6M+2.3% | $112.1M+13.0% | ||
| $39.8M-7.4% | $51.2M-10.8% | $47.3M-8.0% | $40.5M-10.4% | $43M+13.8% | ||
| $8.5M— | $8.9M— | $9.3M— | —— | —— | ||
| $211.5M+34.2% | $209.8M+49.5% | $212.3M+48.4% | $154.6M+7.9% | $157.6M+7.4% | ||
| $125M— | $125M— | $125M— | —— | —— | ||
| $0.010.0% | —— | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 94.4M+2.4% | 93.5M+2.4% | 93.1M+2.3% | 93.1M+2.4% | 92.2M+1.9% | ||
| 5M0.0% | —— | 5M0.0% | 5M0.0% | 5M0.0% | ||
| 0— | —— | 0— | 0— | 0— | ||
| $1.49B+2.1% | $1.49B+2.1% | $1.49B+2.9% | $1.47B+2.7% | $1.46B+3.0% | ||
| $900K0.0% | $900K0.0% | $900K0.0% | $900K0.0% | $900K0.0% | ||
| 500K0.0% | —— | 500K0.0% | 500K0.0% | 500K0.0% | ||
| $0.010.0% | —— | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 700K0.0% | 700K0.0% | 700K0.0% | 700K0.0% | 700K0.0% | ||
| $0— | —— | $0— | $0-100% | $0-100% | ||
| $13.380.0% | $13.380.0% | $13.380.0% | $13.380.0% | $13.380.0% | ||
| $202M+2.3% | $201.9M-11.1% | $194.7M-16.3% | $192.4M-16.9% | $197.5M-13.9% | ||
| $3.8M— | $3.8M— | $3.8M— | —— | —— | ||
| $4.7M-21.7% | $4.7M-27.7% | $5.6M-15.2% | $5.7M-10.9% | $6M+5.3% | ||
| $0.010.0% | —— | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $150M0.0% | —— | $150M0.0% | $150M0.0% | $150M0.0% | ||
| $94.4M+2.4% | $93.5M+2.4% | $93.1M+2.3% | $93.1M+2.4% | $92.2M+1.9% | ||
| $94.4M+2.4% | $93.5M+2.4% | $93.1M+2.3% | $93.1M+2.4% | $92.2M+1.9% | ||
| $125M— | $125M— | $125M— | —— | —— | ||
| $8.5M— | $8.9M— | $9.3M— | —— | —— | ||
| $0— | —— | $0— | $0-100% | $0-100% | ||
| $366.3M+8.2% | $358.5M+9.0% | $352.8M+10.6% | $347.6M+12.7% | $338.4M+10.3% | ||
| $512M-14.1% | $511.9M-13.4% | $515.9M-18.3% | $517.7M-17.5% | $595.9M-8.0% | ||
| $20.1M-27.4% | $15.4M-31.9% | $24.3M+24.6% | $23.8M+65.3% | $27.7M+62.0% | ||
| $0.010.0% | —— | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $5M0.0% | —— | $5M0.0% | $5M0.0% | $5M0.0% | ||
| $0— | —— | $0— | $0— | $0— | ||
| $19.3M+2.1% | $19.9M0.0% | $18.5M-3.6% | $18M-8.6% | $18.9M-1.0% | ||
| $500K0.0% | —— | $500K0.0% | $500K0.0% | $500K0.0% | ||
| $700K0.0% | $700K0.0% | $700K0.0% | $700K0.0% | $700K0.0% | ||
| $13.380.0% | $13.380.0% | $13.380.0% | $13.380.0% | $13.380.0% | ||
| $13.380.0% | —— | $13.380.0% | $13.380.0% | $13.380.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Myriad Genetics's total assets?
- Myriad Genetics (MYGN) holds $673.7M in total assets, down 33.0% year over year.
- How much debt does Myriad Genetics have?
- Myriad Genetics carries $211.5M in total debt against $337.4M of shareholders' equity, a debt-to-equity ratio of 0.63.
- How much cash does Myriad Genetics have?
- Myriad Genetics holds $126.0M in cash and equivalents.
- Can Myriad Genetics cover its short-term obligations?
- Its current ratio is 2.40 — current assets exceed current liabilities.
- Where does Myriad Genetics's balance sheet data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
